Related Experiment Video

Updated: Jul 6, 2026

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Tools to study the function of the Ras-related, estrogen-regulated growth inhibitor in breast cancer

Ariella B Hanker1, Staeci Morita, Gretchen A Repasky

  • 1Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Methods in Enzymology
|April 1, 2008
PubMed

Insights

Ras-related, estrogen-regulated growth inhibitor (Rerg) is a tumor suppressor absent in aggressive ER-negative breast cancers. New tools enable study of Rerg

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The Ras-related, estrogen-regulated growth inhibitor (Rerg) is a small GTPase and potential tumor suppressor.
  • Rerg expression is stimulated by estrogen receptor alpha (ERalpha) and is absent in ER-negative breast cancers, which are aggressive and metastatic.
  • While Rerg exhibits growth inhibitory activity in breast cancer cells, its precise role in cancer progression and underlying mechanisms remain unclear.

Purpose of the Study:

  • To describe tools for detecting and manipulating Rerg expression in breast cancer cells.
  • To facilitate the investigation of Rerg's biological function and its role in breast cancer.

Main Methods:

  • Validation of an antibody for Rerg expression detection.
  • Generation of expression vectors for wild-type and mutant Rerg, focusing on GDP/GTP regulation.
  • Development of an inducible Rerg expression system.
  • Implementation of a retrovirus-based RNA interference (RNAi) approach to suppress Rerg expression.

Main Results:

  • Established methods for detecting Rerg protein levels.
  • Created tools to express varying forms of Rerg, including GTP/GDP binding mutants.
  • Developed systems for controlled Rerg induction and knockdown.
  • These tools provide a foundation for functional studies.

Conclusions:

  • The developed tools are essential for dissecting the biological significance of Rerg in breast cancer.
  • Further research using these tools will elucidate Rerg's function in tumor suppression and its therapeutic potential.
  • Understanding Rerg's role can inform strategies for treating ER-negative breast cancers.

More Related Videos

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...